Phathom Pharmaceuticals Inc (PHAT)
7.50
-0.11
(-1.45%)
USD |
NASDAQ |
Dec 24, 16:00
Phathom Pharmaceuticals Shareholders Equity (Quarterly): -187.11M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 44.50B |
| Galectin Therapeutics Inc | -92.48M |
| AbbVie Inc | 6.032B |
| Poseida Therapeutics Inc | 87.21M |
| Janux Therapeutics Inc | 656.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 387.04M |
| Total Liabilities (Quarterly) | 574.16M |
| Debt to Equity Ratio | -0.9392 |
| Current Ratio | 5.726 |
| Net Debt Paydown Yield | -0.44% |